NASDAQ:WBA - Walgreens Boots Alliance Stock Price, News, & Analysis

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Walgreens Boots Alliance announced a quarterly dividend on Thursday, October 25th. Shareholders of record on Monday, November 12th will be paid a dividend of $0.44 per share on Wednesday, December 12th. This represents a $1.76 annualized dividend and a yield of 2.17%. The ex-dividend date of this dividend is Thursday, November 8th. View Walgreens Boots Alliance's Dividend History.

Walgreens Boots Alliance declared that its board has authorized a stock buyback program on Thursday, October 26th 2017, which authorizes the company to repurchase $1,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are generally an indication that the company's board of directors believes its stock is undervalued.

Walgreens Boots Alliance Inc (NASDAQ:WBA) issued its quarterly earnings data on Thursday, October, 11th. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.45 by $0.03. The pharmacy operator had revenue of $33.44 billion for the quarter, compared to the consensus estimate of $33.64 billion. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. View Walgreens Boots Alliance's Earnings History.

Walgreens Boots Alliance is scheduled to release their next quarterly earnings announcement on Thursday, January 3rd 2019. View Earnings Estimates for Walgreens Boots Alliance.

Walgreens Boots Alliance issued an update on its FY19 earnings guidance on Sunday, October, 14th. The company provided earnings per share (EPS) guidance of 6.40-6.70 for the period, compared to the Thomson Reuters consensus estimate of $6.42.

17 equities research analysts have issued twelve-month target prices for Walgreens Boots Alliance's shares. Their predictions range from $60.00 to $104.00. On average, they expect Walgreens Boots Alliance's share price to reach $78.1176 in the next year. This suggests that the stock has a possible downside of 3.8%. View Analyst Price Targets for Walgreens Boots Alliance.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 1 sell rating, 10 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Walgreens Boots Alliance.

News articles about WBA stock have trended somewhat positive this week, according to InfoTrie. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Walgreens Boots Alliance earned a coverage optimism score of 2.0 on InfoTrie's scale. They also gave media headlines about the pharmacy operator a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an impact on the company's share price in the next few days.

Some companies that are related to Walgreens Boots Alliance include CVS Health (CVS), Express Scripts (ESRX), Diplomat Pharmacy (DPLO), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Walgreens Boots Alliance's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.44%), BlackRock Inc. (5.56%), Franklin Resources Inc. (1.98%), Capital World Investors (1.91%), Bank of New York Mellon Corp (1.23%) and Capital International Investors (1.22%). Company insiders that own Walgreens Boots Alliance stock include Janice M Babiak, John Anthony Lederer, Kathleen Wilson-Thompson, Kimberly R Scardino, Nancy M Schlichting, Ornella Barra, Stefano Pessina and William C Foote. View Institutional Ownership Trends for Walgreens Boots Alliance.

WBA stock was sold by a variety of institutional investors in the last quarter, including Man Group plc, American Century Companies Inc., Capital Research Global Investors, Mitsubishi UFJ Trust & Banking Corp, CI Global Investments Inc., Massachusetts Financial Services Co. MA, Canada Pension Plan Investment Board and TIAA CREF Investment Management LLC. Company insiders that have sold Walgreens Boots Alliance company stock in the last year include Kathleen Wilson-Thompson, Kimberly R Scardino, Nancy M Schlichting and William C Foote. View Insider Buying and Selling for Walgreens Boots Alliance.

WBA stock was purchased by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Franklin Resources Inc., Capital World Investors, LSV Asset Management, Capital International Investors, Morgan Stanley, Mackenzie Financial Corp and FMR LLC. Company insiders that have bought Walgreens Boots Alliance stock in the last two years include Janice M Babiak, John Anthony Lederer, Ornella Barra and Stefano Pessina. View Insider Buying and Selling for Walgreens Boots Alliance.

Shares of WBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of WBA stock can currently be purchased for approximately $81.19.

Walgreens Boots Alliance has a market capitalization of $77.06 billion and generates $131.54 billion in revenue each year. The pharmacy operator earns $5.02 billion in net income (profit) each year or $6.02 on an earnings per share basis. Walgreens Boots Alliance employs 354,000 workers across the globe.

The official website for Walgreens Boots Alliance is http://www.walgreensbootsalliance.com.

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator can be reached via phone at 847-315-2500 or via email at [email protected]